Results 231 to 240 of about 30,793 (265)
Some of the next articles are maybe not open access.
Targeting Neoantigens for Personalised Immunotherapy
BioDrugs, 2018This review discusses the rapidly evolving field of immunotherapy research, focusing on the types of cancer antigens that can be recognised by the immune system and potential methods by which neoantigens can be exploited clinically to successfully target and clear tumour cells.
openaire +2 more sources
Neoantigen Vaccines in Cancer Prevention
The Cancer JournalRecent advances in cancer immunotherapy have established neoantigen-based vaccines as a promising approach to cancer prevention. Unlike tumor-associated antigens, neoantigens originate exclusively from somatic mutations, thus enabling tumor-specific targeting without harm to normal tissues.
Abel Martel-Martel +2 more
openaire +2 more sources
Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
International Journal of Molecular Sciences, 2022Kanako Shimizu, Shin-Ichiro Fujii
exaly
Development of Neoantigens: From Identification in Cancer Cells to Application in Cancer Vaccines
Expert Review of Vaccines, 2022Michael R. Hamblin +2 more
exaly
Identification of Neoantigens for Individualized Therapeutic Cancer Vaccines
Nature Reviews Drug Discovery, 2022Özlem Türeci +2 more
exaly
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity Against Cancers
Pharmaceutics, 2022Shuen-Iu Hung +2 more
exaly
Identification of Alternative Splicing-Derived Cancer Neoantigens for mRNA Vaccine Development.
Briefings in Bioinformatics, 2022Pingping Wang +2 more
exaly

